[go: up one dir, main page]

NO984602L - FremgangsmÕte ved pÕvisning av prion-medierte sykdommer - Google Patents

FremgangsmÕte ved pÕvisning av prion-medierte sykdommer

Info

Publication number
NO984602L
NO984602L NO984602A NO984602A NO984602L NO 984602 L NO984602 L NO 984602L NO 984602 A NO984602 A NO 984602A NO 984602 A NO984602 A NO 984602A NO 984602 L NO984602 L NO 984602L
Authority
NO
Norway
Prior art keywords
prion
procedure
detection
mediated diseases
mediated
Prior art date
Application number
NO984602A
Other languages
English (en)
Other versions
NO984602D0 (no
NO321571B1 (no
Inventor
Bram Edward Cornelis Schreuder
Lucius Johannes Mattheu Keulen
Maria Elisabeth Wilhel Vromans
Johannes Pieter Mari Langeveld
Marinus Adrianus Smits
Original Assignee
Stichting Inst Dierhouderij
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO984602(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Inst Dierhouderij filed Critical Stichting Inst Dierhouderij
Publication of NO984602D0 publication Critical patent/NO984602D0/no
Publication of NO984602L publication Critical patent/NO984602L/no
Publication of NO321571B1 publication Critical patent/NO321571B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19984602A 1996-04-03 1998-10-01 Fremgangsmate for immunologisk pavisning av prionsykdom, diagnostisk testsett til slik pavisning, samt anvendelse av testsettet. NO321571B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200917 1996-04-03
PCT/NL1997/000166 WO1997037227A1 (en) 1996-04-03 1997-04-02 Method for the detection of prion diseases

Publications (3)

Publication Number Publication Date
NO984602D0 NO984602D0 (no) 1998-10-01
NO984602L true NO984602L (no) 1998-12-03
NO321571B1 NO321571B1 (no) 2006-06-06

Family

ID=8223847

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984602A NO321571B1 (no) 1996-04-03 1998-10-01 Fremgangsmate for immunologisk pavisning av prionsykdom, diagnostisk testsett til slik pavisning, samt anvendelse av testsettet.

Country Status (13)

Country Link
US (2) US6972177B1 (no)
EP (1) EP0891552B2 (no)
JP (1) JP3333213B2 (no)
AR (1) AR006494A1 (no)
AT (1) ATE236407T1 (no)
AU (1) AU713529B2 (no)
BR (1) BR9708421A (no)
CA (1) CA2250800C (no)
DE (1) DE69720433T3 (no)
DK (1) DK0891552T4 (no)
NO (1) NO321571B1 (no)
NZ (1) NZ332132A (no)
WO (1) WO1997037227A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2319607A (en) * 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
NZ333518A (en) * 1997-02-06 2001-06-29 Enfer Technology Ltd Immunological assay for spongiform encephalopathies (TSE)
US6165784A (en) * 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
DE19804216C2 (de) * 1998-02-03 1999-12-16 Schebo Tech Gmbh Verfahren zum Nachweis von zentralnervösem Gewebe in Erzeugnissen, insbesondere in Fleischerzeugnissen, sowie ein Testkit hierzu
US7344842B1 (en) * 1999-02-11 2008-03-18 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid Prion test
US6605445B1 (en) 1999-02-22 2003-08-12 Bayer Corporation Rapid method of determining clearance of prion protein
DE19918141A1 (de) * 1999-04-21 2000-10-26 Boehringer Ingelheim Vetmed Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien
WO2001019867A1 (de) * 1999-09-14 2001-03-22 Memorec Stoffel Gmbh Prionen-verwandtes protein
FR2806802B1 (fr) * 2000-03-24 2002-06-21 Eurofins Scient Procede et installation pour confirmer l'absence dans la viande de proteines prion infectieuses
DE10108099A1 (de) * 2001-02-19 2002-09-12 Cenas Ag Verfahren zum Nachweis spezifischer Proteine und Verwendung
EP1382971A1 (en) * 2002-07-17 2004-01-21 Pepscan Systems B.V. Detection of prion disease
US20060184001A1 (en) * 2005-02-02 2006-08-17 Minkoff Lawrence A Method for MRI scanning of animals for transmissible spongiform encephalopathies
KR20080048527A (ko) 2005-09-09 2008-06-02 노파르티스 아게 프리온-특이적 펩토이드 시약
EP2403871A4 (en) * 2009-03-02 2013-01-16 Univ British Columbia FOR ABUSED PRION PROTEIN SPECIFIC ANTIBODIES AND EPITOPES
JP5861256B2 (ja) * 2011-01-25 2016-02-16 富士通株式会社 農作業支援方法及び農作業支援装置
US20220313802A1 (en) * 2019-05-10 2022-10-06 New York University Compositions and methods for the treatment and prevention of prion disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806627A (en) * 1987-05-29 1989-02-21 Research Foundation Of Mental Hygiene Inc. Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins
AU4376093A (en) * 1992-05-15 1993-12-13 Instituto Nazionale Neurologico C. Besta Soluble prion polypeptides, and methods for detecting and purifying thereof
WO1997010505A1 (en) * 1995-09-14 1997-03-20 The Regents Of The University Of California ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
US6165784A (en) 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
US6150172A (en) 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein

Also Published As

Publication number Publication date
DE69720433T2 (de) 2004-03-11
DK0891552T3 (da) 2003-07-21
NZ332132A (en) 2000-02-28
NO984602D0 (no) 1998-10-01
NO321571B1 (no) 2006-06-06
WO1997037227A1 (en) 1997-10-09
EP0891552B2 (en) 2008-12-31
DE69720433T3 (de) 2009-07-30
JP2000505559A (ja) 2000-05-09
AU713529B2 (en) 1999-12-02
US20050048582A1 (en) 2005-03-03
EP0891552B1 (en) 2003-04-02
JP3333213B2 (ja) 2002-10-15
EP0891552A1 (en) 1999-01-20
US6972177B1 (en) 2005-12-06
DE69720433D1 (de) 2003-05-08
BR9708421A (pt) 1999-08-03
CA2250800A1 (en) 1997-10-09
CA2250800C (en) 2004-02-17
ATE236407T1 (de) 2003-04-15
AU2180897A (en) 1997-10-22
AR006494A1 (es) 1999-08-25
US7211401B2 (en) 2007-05-01
DK0891552T4 (da) 2009-05-04

Similar Documents

Publication Publication Date Title
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO984602L (no) FremgangsmÕte ved pÕvisning av prion-medierte sykdommer
NO991382L (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO20000189L (no) Fremgangsmõte for fremstilling av heparin
AU5811498A (en) Microsphere-enhanced immunoassay for the detection of veterinary diseases
AU3596797A (en) Methods for the treatment of apolipoprotein e related diseases
FI963863A0 (fi) Analyyttinen toteaminen
NO995914L (no) Fremgangsmåte for å påvise risiko for trombose
DE69630025D1 (de) Kontrolle eines Infrarotmikroskops
NO955082L (no) Fremgangsmåte for fremstilling av glutardialdehyd
NO991158D0 (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
FI942576A0 (fi) Behandling av plasma
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
NO994749L (no) Fremgangsmåte ved fremstillingen av tetraazamakrocykler
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO953459D0 (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
NO972813L (no) Fremgangsmåte for overvåkning av integritet ved posisjonsbestemmelse
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
NO930436D0 (no) Fremgangsmaate ved fremstilling av baderom
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
NO20002077L (no) FremgangsmÕte ved fremstilling av citalopram
NO20002267D0 (no) FremgangsmÕte ved fremstilling av citalopram
FI964721A0 (fi) Manoevrering av bastuugn

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees